Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jessica Arencibia-Perezleo

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Apr 16, 2025
HER1 (EGFR) and/or HER2 Inclusion Potentiates the Antitumor Effect Elicited by a HER3-Specific Monovalent Vaccine.

Ernesto Bermudez-Abreut, Gretchen Bergado-Báez, Talia Fundora-Barrios

Pageof 1

Frequent Collaborators

1 joint publications

Ernesto Bermúdez-Abreut

1 joint publications

Gretchen Bergado Báez

1 joint publications

Talia Fundora-Barrios

1 joint publications

Armando Lopez Medinilla

1 joint publications

Lisset Chao

1 joint publications

Belinda Sánchez Ramírez

Frequent Collaborators

1 joint publications

Ernesto Bermúdez-Abreut

1 joint publications

Gretchen Bergado Báez

1 joint publications

Talia Fundora-Barrios

1 joint publications

Armando Lopez Medinilla

Top Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on : Jun 18, 2013

11.0K
See more related videos

Top Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on : Jun 18, 2013

11.0K
See more related videos